Chime Financial

CHYM.US experienced a sharp single-session decline during regular trading, opening at $21.35 and dropping steadily to close at $20.83, a loss of 5.0%, and further weakening after hours to $21.724. The stock fell even from its pre-market price of $21.24, indicating broad selling pressure. Financially, Q1 2026 revenue grew 24.8% YoY to $647.4 million, and the company achieved a net profit of $53.5 million, reversing the Q4 2025 loss of $44.8 million, with net margin improving to 8.26%. However, the current price is roughly 5.3% below the 52-week high of $21.93, while the PE ratio stands at -8.3x and PB at 5.51x, highlighting valuation tension despite the earnings turnaround. The after-market saw 52,277 shares traded with a turnover of $1.15 million, suggesting some buying interest persists.

CHYM.US rose during regular trading, reaching $22.545 by ET 10:35, up 5.99% from a pre-market low of $21.27, driven by strong Q1 2026 earnings: revenue of $647.4M (+24.8% YoY) and net profit of $53.5M (vs. -$44.8M in Q4 2025). EPS stood at $0.13, ROE 15.04%, and operating income $135.1M (+14.19% YoY). The stock surged above both MA20 ($19.745) and MA60 ($19.426), yet remains 41.71% below the 52-week high of $38.67 and down 14.62% YTD. However, the negative P/E ratio of -8.99 and PB of 5.96x suggest valuation concerns persist.